Kamada Ltd. Reports Second Quarter 2015 Financial Results
NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three and six months ended June 30, 2015.
Financial highlights of the 2015 second quarter included:
* Total revenues of $19.2 million compared with $15.8 million for the second quarter of 2014;
* Gross profit of $3.6 million compared with a gross loss of $0.10 million in the year-ago second quarter; and
Help employers find you! Check out all the jobs and post your resume.
Financial highlights of the 2015 second quarter included:
* Total revenues of $19.2 million compared with $15.8 million for the second quarter of 2014;
* Gross profit of $3.6 million compared with a gross loss of $0.10 million in the year-ago second quarter; and
Help employers find you! Check out all the jobs and post your resume.